Flow immunocytochemistry of marker expression in cells from body cavity fluids

Awtar Krishan, Parvin Ganjei-Azar, Ronald Hamelik, Deepti Sharma, Isildinha Reis, Mehrdad Nadji

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Diagnostic cytology based on the examination of cells from body cavity fluids misses̃50% of patients with a proven malignancy. In an earlier study, we used immunohistochemical detection of epithelial membrane antigen expression with flow cytometric detection of DNA aneuploidy to reduce the number of false negatives. In the present study, we have combined DNA flow cytometry with flow cytometric detection of marker expression to analyze cells from body cavity fluids. Seventy-nine specimens of ascites and pleural fluids were analyzed by diagnostic cytology, DNA flow cytometry,and for the expression of the following markers: Ber-EP4, progesterone (PR), MUC4,and thyroid transcription factor-1 (TTF-1). DNA index of equal to or greater than 1. 2was seen in 33/79 (41. 7%) of the samples. Statistical analysis of 79 samples in which data from cytology, DNA aneuploidy, and expression of at least one of the markers was available showed that by combining data from positive marker expression with that of aneuploidy, the sensitivity was increased from 58. 5 to 100%. In contrast, out of the 38 samples designated as non-malignant by diagnostic cytology, nine had aneuploid DNA content and 16 of the diploid samples had a positive marker expression. Specificity was reduced from 74. 7 to 31. 6% due to the presence of aneuploidy and marker expression in these samples. ALDH1pos/CD44pos/CD24neg expression has been reported to be associated with human breast tumor stem cells. Some of our samples had cells with this phenotype. Flow cytometry offers the advantage of rapid multiparametric analysis of DNA aneuploidy and marker expression in cells from body cavity fluids based on the analysis of a large number of cells without observer bias. By further developing the use of specific markers and aneuploidy, it may be possible to refine flow cytometric analysis for rapid detection of malignant cells in body cavity fluids.

Original languageEnglish
Pages (from-to)132-143
Number of pages12
JournalCytometry Part A
Volume77
Issue number2
DOIs
StatePublished - Feb 1 2010

Fingerprint

Body Fluids
Aneuploidy
Immunohistochemistry
Cell Biology
DNA
Flow Cytometry
Mucin-1
Observer Variation
Neoplastic Stem Cells
Cell Body
Diploidy
Genetic Markers
Ascites
Progesterone
Cell Count
Breast Neoplasms
Phenotype
Neoplasms

Keywords

  • Cells in body cavity fluids
  • Flow cytometry
  • Immunocytochemistry
  • Tumor associated markers

ASJC Scopus subject areas

  • Cell Biology
  • Histology
  • Pathology and Forensic Medicine

Cite this

Flow immunocytochemistry of marker expression in cells from body cavity fluids. / Krishan, Awtar; Ganjei-Azar, Parvin; Hamelik, Ronald; Sharma, Deepti; Reis, Isildinha; Nadji, Mehrdad.

In: Cytometry Part A, Vol. 77, No. 2, 01.02.2010, p. 132-143.

Research output: Contribution to journalArticle

Krishan, Awtar ; Ganjei-Azar, Parvin ; Hamelik, Ronald ; Sharma, Deepti ; Reis, Isildinha ; Nadji, Mehrdad. / Flow immunocytochemistry of marker expression in cells from body cavity fluids. In: Cytometry Part A. 2010 ; Vol. 77, No. 2. pp. 132-143.
@article{ce09e051aba2441d9648bcfe1be8659f,
title = "Flow immunocytochemistry of marker expression in cells from body cavity fluids",
abstract = "Diagnostic cytology based on the examination of cells from body cavity fluids misses̃50{\%} of patients with a proven malignancy. In an earlier study, we used immunohistochemical detection of epithelial membrane antigen expression with flow cytometric detection of DNA aneuploidy to reduce the number of false negatives. In the present study, we have combined DNA flow cytometry with flow cytometric detection of marker expression to analyze cells from body cavity fluids. Seventy-nine specimens of ascites and pleural fluids were analyzed by diagnostic cytology, DNA flow cytometry,and for the expression of the following markers: Ber-EP4, progesterone (PR), MUC4,and thyroid transcription factor-1 (TTF-1). DNA index of equal to or greater than 1. 2was seen in 33/79 (41. 7{\%}) of the samples. Statistical analysis of 79 samples in which data from cytology, DNA aneuploidy, and expression of at least one of the markers was available showed that by combining data from positive marker expression with that of aneuploidy, the sensitivity was increased from 58. 5 to 100{\%}. In contrast, out of the 38 samples designated as non-malignant by diagnostic cytology, nine had aneuploid DNA content and 16 of the diploid samples had a positive marker expression. Specificity was reduced from 74. 7 to 31. 6{\%} due to the presence of aneuploidy and marker expression in these samples. ALDH1pos/CD44pos/CD24neg expression has been reported to be associated with human breast tumor stem cells. Some of our samples had cells with this phenotype. Flow cytometry offers the advantage of rapid multiparametric analysis of DNA aneuploidy and marker expression in cells from body cavity fluids based on the analysis of a large number of cells without observer bias. By further developing the use of specific markers and aneuploidy, it may be possible to refine flow cytometric analysis for rapid detection of malignant cells in body cavity fluids.",
keywords = "Cells in body cavity fluids, Flow cytometry, Immunocytochemistry, Tumor associated markers",
author = "Awtar Krishan and Parvin Ganjei-Azar and Ronald Hamelik and Deepti Sharma and Isildinha Reis and Mehrdad Nadji",
year = "2010",
month = "2",
day = "1",
doi = "10.1002/cyto.a.20824",
language = "English",
volume = "77",
pages = "132--143",
journal = "Cytometry. Part A : the journal of the International Society for Analytical Cytology",
issn = "1552-4922",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Flow immunocytochemistry of marker expression in cells from body cavity fluids

AU - Krishan, Awtar

AU - Ganjei-Azar, Parvin

AU - Hamelik, Ronald

AU - Sharma, Deepti

AU - Reis, Isildinha

AU - Nadji, Mehrdad

PY - 2010/2/1

Y1 - 2010/2/1

N2 - Diagnostic cytology based on the examination of cells from body cavity fluids misses̃50% of patients with a proven malignancy. In an earlier study, we used immunohistochemical detection of epithelial membrane antigen expression with flow cytometric detection of DNA aneuploidy to reduce the number of false negatives. In the present study, we have combined DNA flow cytometry with flow cytometric detection of marker expression to analyze cells from body cavity fluids. Seventy-nine specimens of ascites and pleural fluids were analyzed by diagnostic cytology, DNA flow cytometry,and for the expression of the following markers: Ber-EP4, progesterone (PR), MUC4,and thyroid transcription factor-1 (TTF-1). DNA index of equal to or greater than 1. 2was seen in 33/79 (41. 7%) of the samples. Statistical analysis of 79 samples in which data from cytology, DNA aneuploidy, and expression of at least one of the markers was available showed that by combining data from positive marker expression with that of aneuploidy, the sensitivity was increased from 58. 5 to 100%. In contrast, out of the 38 samples designated as non-malignant by diagnostic cytology, nine had aneuploid DNA content and 16 of the diploid samples had a positive marker expression. Specificity was reduced from 74. 7 to 31. 6% due to the presence of aneuploidy and marker expression in these samples. ALDH1pos/CD44pos/CD24neg expression has been reported to be associated with human breast tumor stem cells. Some of our samples had cells with this phenotype. Flow cytometry offers the advantage of rapid multiparametric analysis of DNA aneuploidy and marker expression in cells from body cavity fluids based on the analysis of a large number of cells without observer bias. By further developing the use of specific markers and aneuploidy, it may be possible to refine flow cytometric analysis for rapid detection of malignant cells in body cavity fluids.

AB - Diagnostic cytology based on the examination of cells from body cavity fluids misses̃50% of patients with a proven malignancy. In an earlier study, we used immunohistochemical detection of epithelial membrane antigen expression with flow cytometric detection of DNA aneuploidy to reduce the number of false negatives. In the present study, we have combined DNA flow cytometry with flow cytometric detection of marker expression to analyze cells from body cavity fluids. Seventy-nine specimens of ascites and pleural fluids were analyzed by diagnostic cytology, DNA flow cytometry,and for the expression of the following markers: Ber-EP4, progesterone (PR), MUC4,and thyroid transcription factor-1 (TTF-1). DNA index of equal to or greater than 1. 2was seen in 33/79 (41. 7%) of the samples. Statistical analysis of 79 samples in which data from cytology, DNA aneuploidy, and expression of at least one of the markers was available showed that by combining data from positive marker expression with that of aneuploidy, the sensitivity was increased from 58. 5 to 100%. In contrast, out of the 38 samples designated as non-malignant by diagnostic cytology, nine had aneuploid DNA content and 16 of the diploid samples had a positive marker expression. Specificity was reduced from 74. 7 to 31. 6% due to the presence of aneuploidy and marker expression in these samples. ALDH1pos/CD44pos/CD24neg expression has been reported to be associated with human breast tumor stem cells. Some of our samples had cells with this phenotype. Flow cytometry offers the advantage of rapid multiparametric analysis of DNA aneuploidy and marker expression in cells from body cavity fluids based on the analysis of a large number of cells without observer bias. By further developing the use of specific markers and aneuploidy, it may be possible to refine flow cytometric analysis for rapid detection of malignant cells in body cavity fluids.

KW - Cells in body cavity fluids

KW - Flow cytometry

KW - Immunocytochemistry

KW - Tumor associated markers

UR - http://www.scopus.com/inward/record.url?scp=77249113262&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77249113262&partnerID=8YFLogxK

U2 - 10.1002/cyto.a.20824

DO - 10.1002/cyto.a.20824

M3 - Article

C2 - 19899128

AN - SCOPUS:77249113262

VL - 77

SP - 132

EP - 143

JO - Cytometry. Part A : the journal of the International Society for Analytical Cytology

JF - Cytometry. Part A : the journal of the International Society for Analytical Cytology

SN - 1552-4922

IS - 2

ER -